DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICE
Dobutamine is inotropic drug indicated in systolic dysfunction. Data on dobutamine pharmacology, its effects on hemodynamics, coronary and peripheral blood flow, myocardial electrophysiology are presented. Clinical usage and the main contraindications of dobutamine are discussed.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_25c6e7ad058c430a932f76dd9227e785 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a M. Yu. Giljarov |e author |
| 245 | 0 | 0 | |a DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICE |
| 260 | |b Столичная издательская компания, |c 2016-01-01T00:00:00Z. | ||
| 500 | |a 1819-6446 | ||
| 500 | |a 2225-3653 | ||
| 500 | |a 10.20996/1819-6446-2008-4-5-67-70 | ||
| 520 | |a Dobutamine is inotropic drug indicated in systolic dysfunction. Data on dobutamine pharmacology, its effects on hemodynamics, coronary and peripheral blood flow, myocardial electrophysiology are presented. Clinical usage and the main contraindications of dobutamine are discussed. | ||
| 546 | |a EN | ||
| 546 | |a RU | ||
| 690 | |a dobutamine | ||
| 690 | |a inotropic drugs | ||
| 690 | |a acute and chronic heart failure | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Diseases of the circulatory (Cardiovascular) system | ||
| 690 | |a RC666-701 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 4, Iss 5, Pp 67-70 (2016) | |
| 787 | 0 | |n https://www.rpcardio.online/jour/article/view/1160 | |
| 787 | 0 | |n https://doaj.org/toc/1819-6446 | |
| 787 | 0 | |n https://doaj.org/toc/2225-3653 | |
| 856 | 4 | 1 | |u https://doaj.org/article/25c6e7ad058c430a932f76dd9227e785 |z Connect to this object online. |